Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2010
10/21/2010US20100267753 Methods of treating disorders associated with protein kinase ck2 activity
10/21/2010US20100267749 Trisubstituted furopyrimidines and use thereof
10/21/2010US20100267736 Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors
10/21/2010US20100267735 Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors
10/21/2010US20100267685 Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones
10/21/2010US20100267669 Heterocyclic cetp inhibitors
10/21/2010US20100267661 Beta glucans and methods of use thereof
10/21/2010US20100267638 Exosite-directed thrombin inhibitors
10/21/2010US20100267633 N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100267618 Methods for treating congestive heart failure
10/21/2010US20100267046 Isoform-selective inhibitor and activators of pde3 cyclic nucleotide phosphodiesterases
10/21/2010US20100266697 Mixed ligand surface-modified nanoparticles
10/21/2010US20100266591 Method of treating erythropoietin hyporesponsive anemias
10/21/2010US20100266586 Variable antibodies
10/21/2010US20100266571 Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
10/21/2010US20100266556 Method for expanding hematopoietic stem cells using heterocyclic compound
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266529 Using granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine mutein as therapeutic in treatment of neutropenia
10/21/2010US20100266527 Anti-microbial polymers and their compositions
10/21/2010US20100266526 Combination therapy for treating hypercholesterolemia
10/21/2010CA2758698A1 Vitamin d receptor agonists and uses thereof
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/21/2010CA2758136A1 Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability
10/21/2010CA2756685A1 Emulsions of perfluorocarbons
10/20/2010EP2241315A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
10/20/2010EP2240487A1 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
10/20/2010EP2240486A1 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
10/20/2010EP2240475A1 Thiazole derivatives used as pi 3 kinase inhibitors
10/20/2010EP2240179A2 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments
10/20/2010EP2240178A1 Prolyl hydroxylase inhibitors
10/20/2010EP1951653B1 Salicylic acid derivatives
10/20/2010EP1921065B1 Phenylpyridone derivative
10/20/2010EP1747778B1 Anti-fatigue composition
10/20/2010EP1282693B1 Human coagulation factor vii variants
10/20/2010CN1994155B Healthy oral liquid and preparation method thereof
10/20/2010CN101868230A Differentiation promoter and/or proliferation promoter for erythrocyte stem cells, use of methionine for preventing or treating senile anemia, and compositions containing methionine
10/20/2010CN101863982A Fusion protein for increasing blood platelets and preparation method thereof
10/20/2010CN101863889A Method for purifying calcium levofolinate
10/20/2010CN101863871A Total glycosides of Rhodiola rosea, medical application and preparation method thereof
10/20/2010CN101862469A Chitosan derivative quick hemostasis granules and preparation method thereof
10/20/2010CN101862446A SOD (Super Oxide Dismutase) grape health care wine
10/20/2010CN101862415A Method for preparing nutritious liquor
10/20/2010CN101862392A New pharmaceutical application of cordate houttuynia in thrombus prevention
10/20/2010CN101862387A Chinese medicament for treating cerebral thrombosis
10/20/2010CN101862381A Traditional Chinese medicine compound having function of curing anemia and preparation method thereof
10/20/2010CN101862370A Separation method of broussonetia active ingredients
10/20/2010CN101862362A Hydroxypropyl-beta-cyclodextrin inclusion compound of ginseng essential oil, preparation method and application
10/20/2010CN101862350A Active ingredients of scorpion and application thereof
10/20/2010CN101862349A Effective part of centipede and application thereof
10/20/2010CN101862337A Drug composite containing limaprost and preparation method thereof
10/20/2010CN101862333A Stable sodium levofolinate oral preparation and preparation method thereof
10/20/2010CN101862318A Combined medicament-combined linolenic acid capable of preventing and fundamentally treating thromboembolic diseases
10/20/2010CN101862308A Aeromonas hydrophila micro-capsular oral vaccine
10/19/2010US7816525 Process for the preparation of optically pure tetrahydropterins and derivatives, and specifically of optically pure tetrahydrofolic acid and derivatives thereof, by stereospecific hydrogenation
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816357 Regulation of appetite, antiemetics, immunosuppression, analgesia, inflammation, antinocioception, sedation, and intraocular pressure; synergistic; 2-(4-(Trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-(methylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
10/19/2010US7815921 Using patient's leukocyte concentration after incubation with colony stimulation factor as evaluative tool in predicting susceptibility to infection, bone marrow and autoimmune diseases after chemotherapeutic treatments
10/19/2010CA2451422C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
10/19/2010CA2437409C Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/19/2010CA2409743C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/19/2010CA2390526C Sequence specific dna recombination in eukaryotic cells
10/19/2010CA2385287C Signal sequences for preparing leu-hirudin by secretion by e. coli into the culture medium
10/19/2010CA2381489C G-csf analog compositions and methods
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/14/2010WO2010118435A2 Par-1 activation by metalloproteinase-1 (mmp-1)
10/14/2010WO2010117729A1 Antidotes for factor xa inhibitors and methods of using the same
10/14/2010WO2010117323A1 Method and apparatus for producing heat energy and carbon dioxide
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010WO2010115252A1 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-α MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/14/2010WO2010059244A3 Method for reducing thrombocytopenia and thrombocytopenia-associated mortality
10/14/2010US20100261771 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
10/14/2010US20100261759 Substituted oxazolidinones and their use
10/14/2010US20100261756 method for inhibiting platelet aggregation
10/14/2010US20100261755 Isoxazol-3(2h)-one analogs as therapeutic agents
10/14/2010US20100261736 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular disease
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261662 Utilization of mural thrombus for local drug delivery into vascular tissue
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260828 Modulation of Platelet Aggregation
10/14/2010US20100260816 Induction of immunological tolerance
10/14/2010US20100260750 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
10/14/2010US20100260741 Factor VII or VIIa Polypeptide Variants
10/14/2010US20100260730 SHIP-Deficiency to Increase Megakaryocyte Progenitor Production
10/14/2010US20100260706 Compositions and methods for improving production of recombinant polypeptides
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010DE102009015917A1 Use of an active agent comprising resveratrol, thymol, xanthohumol or vitamin C for inhibition and/or prophylaxis of e.g. eryptosis, acute renal failure, anemia, shock, atherosclerosis, thrombosis, diabetes mellitus and sickle cell anemia
10/14/2010CA2758322A1 Par-1 activation by metalloproteinase-1 (mmp-1)
10/14/2010CA2757998A1 Methods of treating edema related to ischemia-reperfusion
10/14/2010CA2757879A1 Isoxazol-3(2h)-one analogs as therapeutic agents
10/14/2010CA2756542A1 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
10/13/2010EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
10/13/2010EP2238128A2 Heterocyclic pyrazole-carboxamides as p2y12 antagonists
10/13/2010EP2238127A2 Pyrazole-carboxamide derivatives as p2y12 antagonists
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010CN1939922B 5H-thiophene [3,4-C] pyrrole-4,6-diketone derivative for inhibiting cell release tumor necrosis factor
10/13/2010CN1919207B Gariic and medlar capsule
10/13/2010CN1802171B Stable, aqueous solution of human erythropoietin, not containing serum albumin
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 671